Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
J Perinatol ; 36(2): 132-6, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26583945

ABSTRACT

OBJECTIVE: Phototherapy is the standard therapeutic approach for neonatal hyperbilirubinemia. Oxidative effects of phototherapy may have potential harms, including DNA damage. Unconjugated bilirubin (UCB) might also possess antigenotoxic potential. Intensive phototherapy is more efficacious than conventional phototherapy in treating hyperbilirubinemia. This study aimed to assess the impact of hyperbilirubinemia and the two different types of phototherapy on DNA damage in peripheral blood mononuclear cells of neonates. STUDY DESIGN: The study was conducted on term neonates with non-hemolytic hyperbilirubinemia and control healthy neonates. Genotoxicity was assessed using single-cell gel electrophoresis (Comet assay) in peripheral mononuclear cells. Blood samples were obtained at enrollment in all infants and after intensive or conventional phototherapy in jaundiced infants. RESULT: DNA damage did not significantly differ between jaundiced and non-jaundiced neonates (11.4±8.7 and 10.9±8.3 arbitrary units (AU), respectively, P=0.58). It increased significantly after exposure to phototherapy compared with prephototherapy values (45.6±14.7 vs 11.4±8.7 AU, respectively, P<0.001). The duration of phototherapy correlated positively with markers of DNA damage (r=0.86, P<0.001); however, the intensity of used light did not significantly impact genotoxicity. CONCLUSION: Hyperbilirubinemia does not influence DNA damage, whereas both conventional and intensive phototherapy are associated with DNA damage in term infants with hyperbilirubinemia.


Subject(s)
Comet Assay/methods , DNA Damage , Hyperbilirubinemia, Neonatal , Leukocytes, Mononuclear , Phototherapy , Case-Control Studies , Female , Humans , Hyperbilirubinemia, Neonatal/diagnosis , Hyperbilirubinemia, Neonatal/therapy , Infant, Newborn , Leukocytes, Mononuclear/pathology , Leukocytes, Mononuclear/physiology , Male , Mutagenicity Tests/methods , Phototherapy/adverse effects , Phototherapy/methods , Time Factors , Treatment Outcome
2.
Genet Couns ; 26(1): 13-9, 2015.
Article in English | MEDLINE | ID: mdl-26043502

ABSTRACT

The aim of the present study is to test the susceptibility of chromosome 21 malsegregation in young mothers of Down syndrome children using combined micronucleus (MN) assay and FISH analysis. The present study included 62 Egyptian young mothers (age < 30 y) who were divided into 22 mothers of DS offspring and 40 age matched controls. All subjects were subjected to chromosomal analysis, micronucleus assay, and FISH analysis. High statistical significant difference was found between mothers of Down syndrome (MDS) and the controls in the MN percentage (P=0.034). Also there was high statistical significant difference between MDS and the controls in the percentage of positive malsegregation (P =0.0001). The specificity of combined MN% with FISH was 90%, while the sensitivity was 63.6%. Combined MN-FISH test is highly specific but moderately sensitive in assessing the risk of having children with DS in young mothers.


Subject(s)
Chromosome Segregation/genetics , Down Syndrome/genetics , Genetic Testing/methods , Maternal Age , Mothers , Adolescent , Adult , Biomarkers , Female , Genetic Testing/standards , Humans , In Situ Hybridization, Fluorescence , Micronucleus Tests , Sensitivity and Specificity , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL